Biotoxtech Co. Ltd. logo

Biotoxtech Co. Ltd. (086040)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
2,290. 00
+20
+0.8811%
47.68B Market Cap
- P/E Ratio
23.06% Div Yield
8,150 Volume
- Eps
2,270
Previous Close
Add Transaction
Day Range
2,255 2,310
Year Range
1,896 4,115
Want to track 086040 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

086040 closed today higher at ₩2,290, an increase of 0.8811% from yesterday's close, completing a monthly increase of 6.5116% or ₩140. Over the past 12 months, 086040 stock lost -18.5053%.
086040 pays dividends to its shareholders, with the most recent payment made on Mar 23, 2022.
The stock of the company had never split.
The company's stock is traded on one exchange.

086040 Chart

People also search for

Tk Chemical Corp.
1,664
+0.4225%
H.S. Industries Co. Ltd.
2,595
+1.1696%
Motrex Co. Ltd.
5,300
+1.7274%
Digital Daesung Co., Ltd.
8,420
+0.9592%
JTC Inc.
4,160
+1.836%

Biotoxtech Co. Ltd. (086040) FAQ

What is the stock price today?

The current price is ₩2,290.00.

On which exchange is it traded?

Biotoxtech Co. Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 086040.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 23.06%.

What is its market cap?

As of today, the market cap is 47.68B.

Has Biotoxtech Co. Ltd. ever had a stock split?

No, there has never been a stock split.

Biotoxtech Co. Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Biotoxtech Co. Ltd. is a preeminent non-clinical contract research organization (CRO) based in South Korea, dedicated to the safety evaluation of diverse products ranging from pharmaceuticals to biotechnological products. Founded in the year 2000 and with its headquarters in Cheongju, Biotoxtech has established itself as a critical player in the life sciences sector. The organization specializes in conducting comprehensive toxicological assessments to ensure the safety and regulatory compliance of products before they enter the market. With its state-of-the-art facilities and a detailed approach to testing, Biotoxtech caters to the stringent needs of industries such as pharmaceuticals, biotechnology, agrochemicals, and food, facilitating the safe and effective development of new compounds. As a crucial component of the product development and regulatory approval process, Biotoxtech significantly impacts the health and agricultural sectors, offering indispensable data that guide product development decisions, regulatory submissions, and market entry strategies.

Products and Services

  • Comprehensive Toxicology Assessment

    Biotoxtech specializes in thorough toxicology testing to evaluate the safety of pharmaceuticals, chemicals, and biotechnological products. This service ensures that clients’ products meet necessary safety standards for regulatory approval. Through animal testing and mechanistic studies, the company identifies potential toxic effects and assesses the safety and efficacy of new compounds.

  • State-of-the-Art Testing Facilities

    The company prides itself on its advanced testing facilities that enable the handling of complex testing procedures with precision. These facilities are equipped to support studies across a wide range of products, facilitating detailed analyses that contribute significantly to the product development process.

  • Industry Specific Solutions

    Across various industries such as pharmaceuticals, biotechnology, agrochemicals, and food, Biotoxtech offers targeted solutions to meet the specific needs of its clients. These services are designed to navigate the unique regulatory and safety evaluation challenges present in each sector, providing tailored support that ensures the successful development and approval of products.

  • Regulatory Submission and Market Entry Strategy

    Biotoxtech plays a pivotal role in assisting companies with the preparation of regulatory submissions and the formulation of effective market entry strategies. By providing critical data and analyses required for product approval, Biotoxtech helps clients navigate the complex regulatory landscape and achieve successful product launches.

Contact Information

Address: -
Phone: -